Back to search

Article

Multisystem Inflammatory Syndrome in Children Following the SARS-CoV-2 Delta Variant in Denmark: Clinical Phenotype and Risk by Vaccination Status and Compared to the Pre-Delta COVID-19 Era

2022-03-09

Abstract excerpt

Background: Multisystem inflammatory syndrome in children (MIS-C) occurs after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). MIS-C hospitalizations depends on the risk of MIS-C following specific SARS-CoV-2 variants and vaccine effectiveness. <br><br>Methods: This prospective nationwide multicentre cohort study included patients aged 0-17 years in Denmark with MIS-C following the SAR...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
11556992-ffd5-5f52-9f56-85023079cf1e
DOI
10.2139/ssrn.4031587
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Multisystem Inflammatory Syndrome in Children Following the SARS-CoV-2 Delta Variant in Denmark: Clinical Phenotype and Risk by Vaccination Status and Compared to the Pre-Delta COVID-19 EraDOI 10.2139/ssrn.4031587
Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study.Semantic proximity
Clinical Phenotypes and Outcomes in Children with Multisystem Inflammatory Syndrome Across Sars-CoV-2 Variant Eras: A Multinational Study from the 4CE ConsortiumSemantic proximity
Lower Risk of Multisystem Inflammatory Syndrome in Children (MIS-C) with the Delta and Omicron variants of SARS-CoV-2Semantic proximity
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortiumSemantic proximity
Multisystem Inflammatory Syndrome in Children and SARS-CoV-2 Variants: A Two-Year Ambispective Multicentric Cohort Study in Catalonia, SpainSemantic proximity
Multisystem Inflammatory Syndrome in Children and SARS-CoV-2 Variants: A Two-Year Ambispective Multicentric Cohort Study in Catalonia, SpainSemantic proximity
Multisystem Inflammatory Syndrome in Children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain.Semantic proximity
Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) Aged 12–20 Years in the United States Who Received COVID-19 Vaccine, December 2020 through August 2021Semantic proximity
Severe Paediatric COVID-19 and Multisystem Inflammatory Syndrome in Children from Wild-Type to Population Immunity: A Prospective Multicentre Cohort Study with Real-Time ReportingSemantic proximity
Multisystem Inflammatory Syndrome (MIS) Following SARS CoV-2 Vaccinations; A Systematic Review and Meta-AnalysisSemantic proximity
Clinical Subphenotypes of Multisystem Inflammatory Syndrome in Children: An EHR-based cohort study from the RECOVER programSemantic proximity
Multisystem inflammatory syndrome in children is a SARS-CoV-2 triggered Kawasaki disease.Semantic proximity
Select a neighboring publication to make it the new centre.